Rebekah Weston
3PUBLICATIONS
36CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (3)
Sort by Publication Date:
|Mar 30, 2026
Reply to: Signal Worth Trusting-If We Can Reproduce It: Clarifying Overall Response Rate and Progression-Free Survival in BEACON Immuno.Juliet Gray, Rebekah Weston, Simon Gates
|Dec 12, 2025
Dinutuximab Beta Added to Temozolomide-Based Chemotherapy for Children With Relapsed and Refractory Neuroblastoma: Results of the ITCC-SIOPEN BEACON Immuno Phase II Trial.Juliet C Gray, Rebekah Weston, Cormac Owens
|Jan 08, 2024
Bevacizumab, Irinotecan, or Topotecan Added to Temozolomide for Children With Relapsed and Refractory Neuroblastoma: Results of the ITCC-SIOPEN BEACON-Neuroblastoma Trial.Lucas Moreno, Rebekah Weston, Cormac Owens
Pageof 1
Frequent Collaborators
3 joint publications
Lucas Moreno
2 joint publications
Marion Gambart
2 joint publications
C Michel Zwaan
2 joint publications
Karsten Nysom
2 joint publications
Nicolas U Gerber
2 joint publications
Ruth Ladenstein
2 joint publications
Guy Makin
2 joint publications
Sucheta Vaidya
2 joint publications
Natasha van Eijkelenburg
2 joint publications
Deborah A Tweddle
